Psychiatr. praxi. 2022;23(2):121-123 | DOI: 10.36290/psy.2022.026
The case report deals with the selection of suitable psychotropic drugs from the group of antidepressants in a patient with anxiety disorder and at the same time suffering from frequent migraine attacks. The interactions of serotonergic antidepressants and triptans (antimigraine drugs) has been widely described in the literature. We deal with concerns from the development of serotonin syndrome, which can be a life-threatening side effect. In practice, there is a need to assess the clinical severity of each drug interaction so that we do not overestimate or underestimate its importance. By incorrect interpretation of the drug interaction, patient can be endangered with side effects or ineffectiveness of therapy. This case study aims to demonstrate the second case described, where the patient was initially undertreated for fear of interaction, which significantly reduced his quality of life.
Published: June 16, 2022 Show citation